AZ5576（Cat No.:I043911）is a small molecule inhibitor developed to target a specific enzyme involved in cancer cell proliferation and survival. It works by inhibiting key molecular pathways that regulate tumor growth and resistance to cell death. AZ5576 has shown potential in preclinical studies, particularly in cancers resistant to conventional therapies. By selectively targeting these pathways, it aims to reduce tumor progression while minimizing the impact on healthy cells. Ongoing research is focused on evaluating AZ5576’s safety, efficacy, and potential for use in treating various solid tumors and hematologic malignancies.